Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Immunology > Chapter 16- Autoimmunity > Flashcards

Chapter 16- Autoimmunity Flashcards

1
Q

Autoimmune responses

A

Resemble normal immune responses to pathogens in that they are specifically activated by antigens- autoantigens (antigens from our own cells and tissues) give rise to autoreactive effector cells and autoantibodies. Diseases are classified as organ-specific or systemic. 5% of the population in Western countries has an autoimmune disease, and the rarity illustrates that the immune system has evolved multiple mechanisms to prevent self injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Classification of autoimmune diseases

A

Autoimmune diseases are classified as type 2, 3, and 4, given that the tissue-damaging effects resemble the immune cells and factors seen with hypersensitivity reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Type 2 autoimmunity

A

Evolves autoantibodies against cell surface or matrix antigens. Examples- hemolytic anemia, myasthenia gravis, and rheumatic fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Type 3 autoimmunity

A

Involves the formation of immune complexes. The soluble autoantigens are released and bind to the immune complexes, which are deposited in the tissues. Examples- bacterial endocarditis, systemic lupus erythematosus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Type 4 autoimmunity

A

T cells are the major effector cell causing the pathology. Examples- type 1 diabetes, rheumatoid arthritis, multiple sclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Central tolerance

A

Takes place at the sites of lymphocyte maturation and development (thymus, bone marrow). Central tolerance works to eliminate new B and T cells that are specific for self antigens (autoreactive). Not all self antigens are present in the thymus, so autoreactive cells may escape their place of development

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Central tolerance in the thymus

A

In the thymus, positive selection occurs to ensure that T cells can recognize self MHC, and negative selection removes those cells with a high affinity for self antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Central tolerance in the bone marrow

A

During receptor editing, B cells have the opportunity to produce a different light chain and re-form a B cell receptor that is no longer autoreactive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Peripheral tolerance

A

Takes place when central tolerance is not able to eliminate all autoreactive cells. Includes immunological tolerance and regulatory T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Immunological ignorance

A

When immune cells have affinity for a self antigen but do not sense or respond to it. If the antigen is inaccessible found in too low a concentration, or binds to weakly to a receptor to generate an activating signal, the cells specific for this antigen will not be stimulated and will die off

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Regulatory T cells

A

Act to prevent the activation and expansion of autoreactive cells. There are 2 types- natural and induced. If there are mutations in FoxP3 or other factors, this regulatory mechanism can break down and autoimmunity can take place

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Co-activating factors and autoimmune diseases

A

Co-activating factors can result in the activation of ignorant self-reactive cells. Inaccessible antigens, from immunologically privileged sites, like the eyes, gonads, or brain, can be released by tissue injury or inflammation. The eye is one example because lymphocytes don’t enter these organs, so auto-reactive T cells can’t enter and cause problems either. However, trauma to the eye can cause the release of intraocular protein antigens. The intraocular antigens are carried to the lymph nodes where they activate T cells. Then, effector T cells in the blood can travel to the eyes and make them both blind

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Natural regulatory T cells

A

When thymocytes express a T cell receptor specific to a self antigen. The regulatory T cells are allowed to survive, and they are programmed in the thymus to express FoxP3 in response to self antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Change in effector CD4 T cell differentiation

A

When we rely on one type of T cells for an organ (which may be autoreactive), but differentiation switches to another T cell type, and these auto-reactive cells will cause disease. One example is type 1 diabetes mellitus, which depends on TH1 cells. Experimentally switching to TH2 cells inhibits disease. Psoriasis depends on TH17 cells, which cause inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Induced regulatory T cells

A

When a naive T cell recognizes an antigen peripherally and is activated in the presence of cytokine TGF-β. This cytokine causes the activation of FoxP3, which causes the cell to differentiate into a regulatory T cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Functions of regulatory T cells (2)

A
  1. Secrete inhibitory cytokines (IL-10, TGF-b)
  2. Suppress dendritic cell maturation and/or expression of co-stimulatory molecules
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Autoimmune hemolytic anemia symptoms (7)

A
  1. Fatigue
  2. Shortness of breath
  3. Jaundice
  4. Rapid heartbeat and breathing
  5. History of multiple blood transfusions
  6. Dark urine
  7. Splenomegaly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Autoimmune hemolytic anemia diagnosis

A

Testing will reveal severe anemia- hemoglobin is very low. The normal range is 12-15.5, while the patient in this case study has a value of 2.7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Autoimmune hemolytic anemia pathology

A

This disease arises when the patient produces autoantibodies against Rh blood group antigens. When RBCs are bound with IgG antibodies, they are rapidly cleared through uptake by FcγR-expressing macrophages in the spleen. When RBCs are bound with IgM, they fix complement and are cleared by CR1-bearing macrophages. Additionally, antibody-sensitized RBCs can also be lysed via formation of MAC. All of these mechanisms contribute to destroying RBCs faster than they can be produced. 50% of cases are idiopathic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Autoimmune hemolytic anemia treatment

A

Corticosteroids, IVIG, and splenectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Graves disease symptoms (8)

A
  1. A slowly enlarging, painless mass in the front of the neck
  2. Difficulty concentrating
  3. Heart palpitations
  4. Unintentional weight loss
  5. Bulging eyes
  6. Irritability
  7. Thickening skin
  8. Problems sleeping
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Graves disease diagnosis

A

Testing will reveal elevated free levels of thyroid hormones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Treatment of Graves disease

A

Antithyroid drugs, radioactive iodine, and thyroidectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Graves disease pathology

A

Graves disease is the most common cause of hyperthyroidism in the US. It appears suddenly and may be triggered by infection. Occurs when autoantibodies bind to the thyroid stimulating hormone (TSH) receptor. It then stimulates excessive production of thyroid hormone (“hyperthyroidism”)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Myasthenia gravis symptoms

A
  1. Whole body weakness
  2. Tiring easily
  3. Difficulty speaking
  4. Drooping of both eyelids
  5. Trouble chewing and difficulty swallowing solid food
  6. Double vision
  7. Unsteady walking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Myasthenia gravis treatment

A

Acetylcholinesterase inhibitors and immunosuppressant drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Myasthenia gravis epidemiology

A

Prevalence is 4 in 10,000 individuals, found more frequently in females than in males. Patients are also more likely to have other autoimmune conditions, like rheumatoid arthritis or lupus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Myasthenia gravis pathology

A

Autoantibodies against a chain of the nicotinic acetylcholine receptor block the stimulation of muscle contractions. This results in internalization and degradation of the acetylcholine receptor. Patients develop an inability to sustain a maintained or repeated muscle contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Goodpasture syndrome diagnosis

A

Patients present with advanced acute renal failure. Testing reveals hematuria and proteinuria. A renal biopsy shows glomerulonephritis. Further tests reveal the presence of anti-glomerular basement membrane (anti-GBM) antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Glomerulonephritis

A

Inflammation of the tiny filters (glomeruli) in your kidneys. The glomeruli are small ball-shaped structures made of capillaries. They are involved in the filtration of blood to form urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Goodpasture syndrome

A

Where antibodies are formed against type 4 collagen and bind to the basement membranes of renal glomeruli. The antibodies ligate FcgR on monocytes and neutrophils, causing their activation, chemokine release, and further innate cell recruitment. The antibodies also activate complement, causing tissue damage

31
Q

Goodpasture syndrome treatment

A

Immunosuppressive drugs, plasmapheresis alleviate the symptoms

32
Q

Transfer of antibody-mediated autoimmune disease

A

IgG autoantibodies can cross the placenta (through the FcRn receptor) and cause disease in the fetus or newborn. In diseases such as Grave’s disease, Myasthenia gravis, thrombocytopenic purpura (anti-platelet antibodies), and SLE, antibodies are capable of crossing the placenta to cause transient autoimmunity. Symptoms disappear as maternal antibodies are catabolized, however, tissue damage can occur (e.g., heart tissue damage with SLE antibodies)

33
Q

Epitope spreading

A

During a normal immune response against pathogens, we produce effector B cells and T cells against antigens produced by the pathogen. The antigens go away when the pathogen is cleared. However, self antigens are permanent because they are part of the individual. This means that autoreactive B and T cells will always have something to respond against. Chronic inflammation can cause tissue damage and release of additional self antigens. Epitope spreading the recruitment of new clones of B and T cells as self antigens continue to be released. There are 2 types of epitope spreading- intramolecular and intermolecular

34
Q

Intramolecular epitope spreading

A

The immune response is targeting new epitopes on the same antigen that initiated the autoimmune response

35
Q

Intermolecular epitope spreading

A

New autoantigens are released for the immune system to respond to. This is why some people with autoimmune diseases have multiple autoimmune conditions

36
Q

Pemphigus vulgaris

A

Pemphigus vulgaris is a disease categorized by severe blistering of the skin and mucosal membranes. Patients produce autoantibodies against desmogleins- a cadherin in cell junctions that hold cells of the epidermis together. Autoantibodies then cause dissociation of the tight junctions. Initially “harmless” antibodies against the EC5 domain of desmoglein (Dsg-3) are produced. This domain does not cause disease

37
Q

Pemphigus vulgaris and intramolecular epitope spreading

A

As antibodies against EC5 are produced, they can begin to allow uptake of the desmoglein molecule. There is an immune response against additional epitopes, like EC1 and EC2. Antibodies against these domains are pathological, causing lesions in the oral and genital mucosa.

38
Q

Pemphigus vulgaris and intermolecular epitope spreading

A

Immune response to another desmoglein molecule (Dsg-1). This causes deep skin blistering

39
Q

Systemic lupus erythematosus (SLE)

A

An immune complex mediated disease (type 3 hypersensitivity). Prevalence is 20-70 cases per 100,000 people. The patient produces autoantibodies against a wide range of cell-surface and intracellular antigens. A defect in apoptotic clearance leads to apoptotic material being taken up by APCs and development of anti-nuclear antibodies

40
Q

Systemic lupus erythematosus (SLE) symptoms

A

Immune complex deposits result in glomerulonephritis, arthritis, hair loss, fatigue, butterfly-shaped rash. Type 3 autoimmune disease as immune complexes are produced

41
Q

Criteria for SLE

A

Established in 1982 by the American College of Rheumatology, a patient must exhibit at least 4 of 11 signs/symptoms: Butterfly rash
Scaly rash on skin, Pericarditis or pleurisy, Oral Ulcers, Arthritis, Photosensitivity, Blood disorder (anemia, leukopenia, lymphopenia, or low platelets), Kidney disease, Antinuclear antibodies, Anti-ds DNA antibodies, or neurological disorder (seizures, psychosis)

42
Q

SLE immunopathology

A

SLE consists of an immune response against nucleosomes, which are made up of histone proteins and DNA. If apoptosis is occurring normally, these antigens won’t be processed and presented. However, in people who have defects in the clearance of apoptotic cells, these molecules can be presented. CD4 helper T cells have a specificity for a certain peptide from the linker histone. Then, B cells specific for epitopes on the nucleosome bind to and endocytose the intact nucleosome. The histone peptide is presented to CD4 T cells, and the B cells are activated to make autoantibodies

43
Q

Autoantibodies in HLE

A

B cells can be activated to make autoantibodies against histone or DNA self antigens

44
Q

SLE and epitope spreading

A

Immune complexes formed in SLE may present different epitopes to different autoreactive T cells (histone proteins, etc.) which activates a wider range of T cells and broadens the immune response. This is an example of intermolecular spreading

45
Q

Cryptic epitopes

A

When B cells internalize an autoantigen and present novel, previously hidden peptides to autoreactive T cells. The “hidden” immune response then becomes detectable as the new antigens are presented.

46
Q

T cells contribute to autoimmunity by (2)

A
  1. Provide help to autoreactive B cells
  2. Direct effector function- cytokine release, cytotoxicity
47
Q

How can we prove the existence of autoreactive T cells?

A

Difficult to prove due to MHC restriction. CD4 epitopes are also easier to identify than CD8. The epitopes are identifiable by adding cells or tissues containing autoantigens to cultures of patient’s T cells

48
Q

Hashimoto’s thyroiditis

A

The most common cause of hypothyroidism in the US. The thyroid gland is infiltrated with B and T cells (CD4 TH1 helper T cells) and the normal architecture of the thyroid is destroyed. It is reorganized to resemble secondary lymphoid tissue. Patients lose the capacity to make thyroid hormones

49
Q

Hashimoto’s thyroiditis symptoms

A

Symptoms appear slowly- fatigue, weight gain, constipation, increased sensitivity to cold, dry skin, depression, muscle aches

50
Q

Hashimoto’s thyroiditis treatment

A

Synthetic thyroid hormones

51
Q

Type 1 diabetes

A

Make up 5-10% of all diabetes cases. The insulin-producing beta cells are targeted and destroyed by CD8 T cells, which suggests that the autoantigen is unique to b cells (i.e., insulin). On biopsy, the pancreas exhibits insulitis- infiltration of lymphocytes in the islet. One complication is diabetic ketoacidosis due to a lack of insulin and elevated glucagon

52
Q

Type 1 diabetes symptoms

A

Frequent urination, increased thirst, increased hunger, and weight loss, blurry vision, feeling tired, and poor wound healing

53
Q

Multiple sclerosis

A

A T cell mediated, destructive immune response to CNS myelin antigens, including Myelin basic protein (MBP), proteolipid protein (PLP), myelin oligodendrocyte glycoprotein (MOG). There is a dissolution of the myelin sheath surrounding nerve cell axons and inflammatory infiltrates along blood vessels. Lesions and plaques develop in the white matter of the brain

54
Q

Multiple sclerosis symptoms

A

Various neurological symptoms- muscle weakness, ataxia, blindness, paralysis. Patients experience acute attacks followed by relapses, and undergo a steady decline where they become less responsive to therapies

55
Q

Multiple sclerosis immunopathology

A

The CNS is a tightly regulated environment, but with MS there is a breakdown of the blood brain barrier. Activated autoreactive T cells bind to VCAM on the vascular endothelium, and migrate out of the blood vessel into the CNS. TH17 and TH1 cells infiltrate the CNS and secrete cytokines IL-17 and IFN-g. These cytokines exacerbate inflammation, and autoreactive B cells produce autoantibodies

56
Q

Rheumatoid Arthritis

A

Found in 1-3% of the US population, and women are 3 times more likely to develop it than men. It is a chronic disease characterized by inflammation of the synovium (lining of joints). This inflamed synovium leads to cartilage damage and then bone erosion. There is an increased incidence of RA with age, possibly due to senescence and thymic involution

57
Q

Rheumatoid Arthritis symptoms

A

Chronic pain, loss of function, and disability

58
Q

Rheumatoid arthritis immunopathology

A

RA was first thought to be solely autoantibody mediated, but it is a T cell mediated disease. An unknown trigger causes the initial inflammation in the synovial membrane, but is attracts leukocytes to the tissue. Autoreactive CD4 T cells activate macrophages, resulting in the production of pro-inflammatory cytokines and sustained inflammation. The cytokines can also increase the production of molecules that work to break down the joint and cause degradation of the bone. People with certain HLA molecules (HLA-DR) are more likely to develop RA

59
Q

Rheumatoid factor

A

The autoantibodies produced by B cells in RA- consists of IgM, IgG, and IgA antibodies. These antibodies are not the major factor causing disease, but can be used diagnostically

60
Q

Environmental factors associated with RA

A

Smoking is an environmental factor associated with RA. Smoking induces the expression of PAD and the production of citrullinated proteins, especially in people with HLA-DR4.

61
Q

Infection and autoimmunity

A

Pathogens can induce inflammation and tissue disruption, which can cause the release of sequestered autoantigens. Pro-inflammatory cytokines can also impair regulatory T cells

62
Q

Molecular mimicry

A

An immune response against a pathogen epitope can cause a cross-reaction with self molecules. This results in an autoimmune response

63
Q

Rheumatic fever

A

A generally transient autoimmune response that follows sore throat, scarlet fever, and impetigo. Characterized by damage to the heart valves and kidneys. Damage may be permanent in some individuals and cardiac function can be impaired

64
Q

HLA and predisposition to autoimmunity

A

HLA is the dominant genetic factor in autoimmunity. It accounts for 50% of genetic predisposition. Some haplotypes are more prevalent in certain races, like HLA-DQ2 in Caucasians

65
Q

Rheumatic fever immunopathology

A

When a person is infected with streptococcal bacteria, their immune system produces antibodies against the cell wall of the bacteria. However, some of these antibodies can cross-react with antigens expressed on the heart valves. This is another example of molecular mimicry, where antibodies cross-react with similar antigens

66
Q

Factors influencing susceptibility to autoimmunity

A

Other genes, like those involved in signaling, co-stimulation, and apoptosis may be involved. Gender, age (thymus shrinking) and environmental factors may play a role

67
Q

IVIG

A

Pooled human immunoglobulin, which achieves complete saturation of the FcgR receptor. The saturation may prevent the activation of macrophages. This results in suppression of autoantibodies

68
Q

Anti-idiotypic antibodies

A

Antibodies that bind to antigen-binding site of another antibody (remember antibodies are proteins). May prevent them from binding to self antigens

69
Q

Plasmapheresis

A

When components of blood plasma are filtered and returned to the donor. This process depletes the autoantibodies and immune complexes, as in Goodpasture’s syndrome, myasthenia gravis, and lupus. There is only a transient benefit, so this treatment must be coupled with corticosteroids. Side effects include a risk of infection (we may be removing beneficial antibodies) and clotting problems

70
Q

immunosuppressives

A

Similar drugs are used for allergy and preventing transplant rejection. They impact the expression of several immune genes (20%). Side effects include toxicity and the development of tolerance

71
Q

Rapamycin

A

An immunosuppressive that targets the mammalian target of rapamycin (mTOR), which is the central regulator of mammalian metabolism and physiology. It impacts cell proliferation and growth. Rapamycin also appears to increase the number of regulatory T cells

72
Q

Antibody therapies

A

Experimentally generated monoclonal antibodies that can deplete and block function. Antibodies can be humanized to prevent rejection

73
Q

Anti-TNF-a (Humira)

A

Blocks/neutralizes ability of TNF-a to induce inflammation- it is effective against RA, colitis, and Crohn’s disease. Humira has a long half life (12-14 days) but needs to be combined with methotrexate to suppress T and B cell activation. There are concerns about increased susceptibility to infections due to treatment, such as latent virus and bacterial infections

74
Q

Ex vivo-Expanded Autologous Polyclonal Regulatory T Cell Therapy

A

T cells are isolated from the blood of patients, and the cells are expanded ex vivo. They are assessed for FoxP3 expression and suppressive activity prior to transfer back into patient. Tested in patients suffering from adult type I diabetes (n= 14); more studies needed

75
Q

Citrullinated proteins

A

PAD enzyme converts arginine to citrulline residues, which are neutral in charge. The loss of surface charge makes the proteins more susceptible to proteolysis. Peptides containing citrulline residues are then presented to CD4 T cells in RA

Immunology (17 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions